Respiratory chain dysfunction and oxidative stress correlate with severity of primary CoQ 10 deficiency
- 29 January 2008
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 22 (6), 1874-1885
- https://doi.org/10.1096/fj.07-100149
Abstract
Coenzyme Q(10) (CoQ(10)) is essential for electron transport in the mitochondrial respiratory chain and antioxidant defense. Last year, we reported the first mutations in CoQ(10) biosynthetic genes, COQ2, which encodes 4-parahydroxybenzoate: polyprenyl transferase; and PDSS2, which encodes subunit 2 of decaprenyl diphosphate synthase. However, the pathogenic mechanisms of primary CoQ(10) deficiency have not been well characterized. In this study, we investigated the consequence of severe CoQ(10) deficiency on bioenergetics, oxidative stress, and antioxidant defenses in cultured skin fibroblasts harboring COQ2 and PDSS2 mutations. Defects in the first two committed steps of the CoQ(10) biosynthetic pathway produce different biochemical alterations. PDSS2 mutant fibroblasts have 12% CoQ(10) relative to control cells and markedly reduced ATP synthesis, but do not show increased reactive oxygen species (ROS) production, signs of oxidative stress, or increased antioxidant defense markers. In contrast, COQ2 mutant fibroblasts have 30% CoQ(10) with partial defect in ATP synthesis, as well as significantly increased ROS production and oxidation of lipids and proteins. On the basis of a small number of cell lines, our results suggest that primary CoQ(10) deficiencies cause variable defects of ATP synthesis and oxidative stress, which may explain the different clinical features and may lead to more rational therapeutic strategies.Keywords
Funding Information
- National Institutes of Health (NS‐11766, HD‐32062)
- Muscular Dystrophy Association
This publication has 51 references indexed in Scilit:
- Biochemical phenotypes associated with the mitochondrial ATP6 gene mutations at nt8993Biochimica et Biophysica Acta (BBA) - Bioenergetics, 2007
- Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disordersJCI Insight, 2007
- Mutations in coenzyme Q10 biosynthetic genesJCI Insight, 2007
- Mitochondrial deoxynucleotide pool sizes in mouse liver and evidence for a transport mechanism for thymidine monophosphateProceedings of the National Academy of Sciences of the United States of America, 2006
- Leigh Syndrome with Nephropathy and CoQ10 Deficiency Due to decaprenyl diphosphate synthase subunit 2 (PDSS2) MutationsAmerican Journal of Human Genetics, 2006
- Antioxidant defences in cybrids harboring mtDNA mutations associated with Leber's hereditary optic neuropathyThe FEBS Journal, 2005
- Coenzyme Q and the regulation of intracellular steady‐state levels of superoxide in HL‐60 cellsBioFactors, 2005
- Mitochondrial formation of reactive oxygen speciesJournal Of Physiology-London, 2003
- Nonviability of cells with oxidative defects in galactose medium: A screening test for affected patient fibroblastsBiochemical Medicine and Metabolic Biology, 1992
- Effect of ubiquinone extraction on ubiquinol-1 oxidase activity in beef heart mitochondriaJournal of Bioenergetics and Biomembranes, 1981